Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Renganayaki Pandurengan"'
Autor:
Christine Glendening, Hope Moser, Chunyan Cai, Renganayaki Pandurengan, Carolina Diaz, Abigail Marcotte, Jacqueline Denzler, Jennifer Cao, Nicole Gonzales
Publikováno v:
Stroke. 47
Background: Patients with intracerebral hemorrhage (ICH) frequently present with elevated blood pressure (BP) requiring treatment. We conducted an exploratory analysis to examine BP management during the acute phase of ICH. We hypothesized that BP ma
Autor:
Claire MacDonald, Renganayaki Pandurengan, Navdeep Sangha, James C. Grotta, Amber Jacobs, Andrei V. Alexandrov, Mohammad H. Rahbar, Gary A. Ford, Christine Roffe, Steven R. Levine, Zahra G Ajani, Bart Piechowski, Michael T. Mullen, Andrew D Barreto, Loren F Shen
Publikováno v:
Stroke. 46
Background: Enrollment into acute ischemic stroke (AIS) trials is usually limited to weekday working hours. At our center, the majority of patients (64%) that receive tPA arrive after-hours. As a result, a large portion of eligible patients do not re
Autor:
Tzu-Ching Wu, James C. Grotta, Mohammad H. Rahbar, Andrew D Barreto, Chunyan Cai, Digvijaya Navalkele, Nicole R. Gonzales, Amrou Sarraj, Renganayaki Pandurengan
Publikováno v:
Stroke. 46
Background: Per American Heart Association guidelines, blood pressure (BP) should be < 185/110 to be eligible for intravenous tissue plasminogen activator (tPA). It is shown that door to needle (DTN) time is prolonged in patients who require anti-hyp
Autor:
James C. Grotta, Sheryl Martin-Schild, Hui Peng, Nicole R. Gonzales, Farhaan S Vahidy, William J Hicks, Arvind B Bambhroliya, Hen Hallevi, Tzu-Ching Wu, Mohammad H. Rahbar, Sean I Savitz, Renganayaki Pandurengan, Indrani Acosta, Andrew D Barreto
Publikováno v:
Neurology. 83(5)
Objective: The purpose of this study was to assess the incidence of deterioration, fluctuation, and associated risk of poor outcome in patients with subcortical stroke (SCS). Methods: We conducted a prospective observational study, enrolling patients
Autor:
Farhaan S Vahidy, William J Hicks, Indrani Acosta, Hen Hallevi, Hui Peng, Renganayaki Pandurengan, Nicole Gonzales, Andrew Barreto, Sheryl Martin-Schild, Tzu-Ching Wu, Mohammad H Rahbar, Arvind Bambhroliya, James C Grotta, Sean I Savitz
Publikováno v:
Stroke. 45
Subcortical strokes (SCS) are associated with stroke progression. The primary objective was to assess the incidences of neurological deterioration and its spontaneous reversal in SCS patients. We also estimated the risk of poor outcome associated wit
Autor:
Jarek Aronowski, Navdeep Sangha, Hui Peng, James C. Grotta, Ellie Eun Ju Choi, Jorge Kawano-Castillo, Renganayaki Pandurengan, Nicole R. Gonzales, Mohammad H. Rahbar, Teslyn Kauffman, Rebecca Martinez
Publikováno v:
Stroke. 44
BACKGROUND MRI DWI abnormalities have been reported in 22-35% of patients with intracerebral hemorrhage (ICH). The mechanism underlying these changes is unknown. The timing of development of DWI changes has not been well described. We evaluated the t
Autor:
Waldo R Guerrero, Farhaan Vahidy, Renganayaki Pandurengan, Hui Peng, Tzu-Ching Wu, Sean I Savitz
Publikováno v:
Stroke. 44
Background and Objectives: There is a paucity of data from recent trials analyzing outcomes and hospital complications in octogenarians after acute ischemic stroke (AIS). Stroke trials often set an arbitrary upper age limit (usually age 80) as an inc
Autor:
Mohammad H Rahbar, Nicole R Gonzales, Manouchehr Ardjomand-Hessabi, Amirali Tahanan, Melvin R Sline, Hui Peng, Renganayaki Pandurengan, Farhaan S Vahidy, Jessica D Tanksley, Ayodeji A Delano, Rene M Malazarte, Sean I Savitz, James C Grotta
Publikováno v:
Stroke. 44
Background: Limited information has been published regarding standard procedures to ensure data quality in stroke registries. We share our experience regarding the establishment of enhanced quality assurance (QA) procedures for the University of Texa
Autor:
James C. Grotta, Hui Peng, Indrani Acosta, Susan Alderman, Andrew D Barreto, Renganayaki Pandurengan, William J Hicks, Sean I Savitz, Sheryl Martin-Schild
Publikováno v:
Stroke. 43
Objective: Patients with progressive strokes during hospitalization have increased morbidity and mortality as well as worsened functional outcome compared with those who remain stable. While the reported rate of fluctuations in subcortical stroke pat
Autor:
Andrei V. Alexandrov, Kristian Barlinn, Rebecca M. Sugg, Sheryl Martin-Schild, Zsolt Garami, P. Lyden, Clotilde Balucani, Andrew M. Demchuk, James C. Grotta, Sean I Savitz, Renganayaki Pandurengan, Zhongxue Chen, Robert Mikulik, Nicole R. Gonzales, Jessica Lee, Loren Shen, April Sisson, Tzu C Wu, Andrew D Barreto, Mohammad H. Rahbar, Georgios Tsivgoulis
Publikováno v:
Stroke. 43(3)
Background and Purpose— Argatroban is a direct thrombin inhibitor that safely augments recanalization achieved by tissue-type plasminogen activator (tPA) in animal stroke models. The Argatroban tPA Stroke Study was an open-label, pilot safety study